Cite
HARVARD Citation
Alghazali, M. et al. (2020). Update on a real-world study evaluating overall survival and treatment duration in Swedish patients with metastatic castration-resistant prostate cancer treated with enzalutamide. Scandinavian journal of urology. pp. 263-264. [Online].